The Leukemia, Lymphoma and Multiple Myeloma Program at UC Davis Cancer Center is the largest and most comprehensive program of its kind in inland Northern California. It provides the most advanced methods of diagnosis and treatment possible, including new therapies that often aren't available at community hospitals.

The physicians in our Leukemia, Lymphoma and Multiple Myeloma Program have extensive experience treating both common and uncommon cancers of the blood, bone marrow and lymphatic system. This includes the more than 40 subtypes of lymphoma, as well as such rare malignancies as hairy-cell leukemia.

Our physician-scientists are also at the forefront of research to develop and test new drugs to combat this family of cancers, ensuring that new treatments developed in the lab move quickly to the clinic for the immediate benefit of our patients.

The UC Davis Cancer Center's Leukemia, Lymphoma and Multiple Myeloma Treatment Program is staffed by specialists in:

• hematology and oncology 
• radiation oncology 
• pathology 
• stem cell transplantation 
• nuclear medicine 
• radiology 

This multidisciplinary team of top academic physicians is accustomed to developing and carrying out complex, cutting-edge, rigorous treatment regimens designed to offer each patient the best chance for a cure.

Treatments may include:

• radiation
• radioimmunotherapy (nuclear medicine)
• chemotherapy
• molecular-targeted therapy
• stem cell transplantation

Throughout treatment, our patients have access to the latest technology, including an in-house cytogenetics lab that allows us to study chromosomes in order to provide individualized treatment based on a person's genes. In our bone marrow lab, each specimen is independently reviewed by two specialists, one in pathology and one in hematology and oncology.

UC Davis Cancer Center has one of the nation's largest clinical trials programs, offering patients access to the newest drugs and treatments before they become widely available. The Cancer Center participates in two National Cancer Institute-sponsored adult clinical trials groups: the Southwest Oncology Group, made up of 283 leading cancer treatment and research institutions throughout North America, and the Radiation Therapy Oncology Group, comprising 250 centers. In addition, our physicians conduct novel clinical trials through the California Cancer Consortium, a research collaboration that also includes the City of Hope National Medical Center in Duarte, Calif., and the University of Southern California in Los Angeles.

The UC Davis Leukemia, Lymphoma and Multiple Myeloma Program is dedicated to caring for the whole patient. We offer:

• a leukemia and lymphoma support group
• psychosocial counseling
• patient education, classes, lectures and newsletter
• discounts on gentle yoga classes and massage therapy
• a Cancer Resource Center

Hematology/Oncology

Carol M. Richman, M.D.
Professor of Internal Medicine, Hematology and Oncology
Director, Bone Marrow Transplant Program

Joseph M. Tuscano, M.D., Ph.D.
Associate Professor of Internal Medicine, Hematology and Oncology

Jeanna Welborn, M.D.
Professor of Medicine, Pathology and Laboratory Medicine
Medical Director, Bone Marrow Laboratory, Cytogenetics Laboratory  and Therapeutic Apheresis

Ted Wun, M.D.
Vice Chief of Hematology and Oncology
Director of CTSC Clinical Research Center
Professor of Medicine, Pathology and Laboratory Medicine

Radioimmunotherapy

Robert O'Donnell, M.D., Ph.D.
Professor of Medicine

 To make an appointment, please call (916) 703-5210 or (800) 362-5566.

Updated 10/2008.